AzTrials
AzTrials

GlaucomaNCT03958929

Impact of an Educational Video on Satisfaction After Glaucoma Surgery

A study testing Educational Video in people with Glaucoma, run by Sun Yat-sen University at 1 site in China.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

Overall Objective: This study will assess whether an educational video is effective in increasing patient satisfaction with glaucoma surgery. 1. Investigate the impact of educational interventions on glaucoma patients' surgical satisfaction. 2. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Glaucoma
What is being tested?
Educational Video
Could I receive a placebo?
No, everyone receives an active treatment
How many people
264 participants
Where
1 siteChina
Study dates
10 Oct 2023to 30 Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age≥18 years, glaucoma patients who do the peripheral iridectomy or trabeculotomy

Who cannot join

  • patients who had been the trabeculotomy, vision≤0.05, severe psychotic disorders and dysgnosia

Trial locations and contacts

1 site in 1 country.

China1 site
  • Affiliated Eye Hospital of Nanchang University

    Nanchang, Jiangxi, 330006

Other trials in China

About this study

Official title: A Randomized Controlled Trial on the Impact of an Educational Video on Satisfaction After Glaucoma Surgery in Urban and Rural China

Overall Objective: This study will assess whether an educational video is effective in increasing patient satisfaction with glaucoma surgery.

  1. Investigate the impact of educational interventions on glaucoma patients' surgical satisfaction.
  2. Investigate the post-operative satisfaction of rural glaucoma patients in county hospitals
  3. Investigate the difference in postoperative satisfaction between urban and rural glaucoma patients in urban hospitals
  4. Investigate other factors that influence postoperative glaucoma satisfaction.
Read the detailed description

Glaucoma is the leading cause of irreversible blindness in China, as elsewhere in the world. In Chinese rural settings, where topical glaucoma medication is unlikely to be a practical and sustainable option, surgery is the primary treatment modality for glaucoma.

However, it is known that vision is quite likely to decline in the short to medium term after glaucoma surgery, and there are concerns that dis-satisfaction resulting from such vision changes might lead to negative social marketing, affecting uptake not only of glaucoma surgical care but other eye operations (principally cataract) as well. We propose to test the impact on post-operative satisfaction of a multi-media educational intervention designed to give patients a realistic expectation of their post operative course: glaucoma surgery is being performed NOT to improve vision, but do protect it from future harm, and vision may in fact decline for several weeks post operatively.

A randomized controlled design will be used, and subjects undergoing glaucoma surgery will be enrolled at 4 rural county hospitals in rural Guangdong province, and randomized to receive the intervention or usual care. The principal outcome will be subjective satisfaction on a previously-tested questionnaire instrument, administered pre-operatively and post-operatively on two occasions in the first month following surgery. Patients not returning post-operatively to the surgical facility will be contacted by telephone for administration of the questionnaire. Other facility- and patient-related clinical and personal factors expected to influence satisfaction will also be recorded, and adjusted for in all analyses.

Conditions
Glaucoma
Being tested
Educational Video
Keywords
glaucoma surgery, educational intervention, satisfaction, rural
Medical subject headings
Glaucoma, Personal Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Educational VideoOther

    The film follows the journey of an elderly patient scheduled to undergo glaucoma surgery, beginning with a face-to-face Q\&A health session with an eye doctor. After surgery, the patient talks about his post-operative eyesight and discusses the benefits of early diagnosis and glaucoma surgery for treatment with his community.

Study groups in NCT03958929
Study groupRoleWhat they receive
Education groupExperimentalSubjects will be asked to watch a 5-10 min education film two times (pre-op one day and post-op one day).
Receives: Other: Educational Video
Control groupNo interventionStandard patient procedure that includes a pre-operative discussion with an ophthalmologist about glaucoma surgery, during which the surgeon gains the patient's informed consent. Subjects will not be asked to watch education film..

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The mean satisfaction outcome over two follow-up visits

    The primary outcome is the mean satisfaction score calculated by adding up the satisfaction scores at two follow-up visits: 1 day and 1 week after surgery and dividing the total by the number of scores. The satisfaction score will be assessed as a cumulative score.

    Composite outcome, in which multiple end points are combined, are frequently used as primary outcome measures in randomized trials and are often associated with increased statistical efficiency, although such measure may prove challenging for the interpretation of results. (Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA. 2003; 289: 2554-2559)

    Measured: 1 day, 1 week

Secondary outcomes (5)
  1. The rate of willingness to recommend surgery to a friend or relative with glaucoma

    The measurement method: questionnaire

    Measured: 1 day, 1 week

  2. Personality in both groups using Eysenck Personality Questionnaire-Revised Short Scale for Chinese (EPQ-RSC) access glaucoma patients personality

    The measurement method: questionnaire. The questionnaire provides subscores for 5 categories (Short, Extraversion, Neuroticism, Psychoticism, Lie score), with a higher corresponding to a higher characterization of that particular trait.

    Measured: Baseline (before surgery)

  3. Knowledge scores about glaucoma

    The measurement method: questionnaire.

    Mean knowledge scores is calculated by adding up the scores at two follow-up visits: 1 day and 1 week after surgery and dividing the total by the number of scores. Knowledge scores will be assessed as a cumulative score, and will be compared with the baseline pre-operative score.

    Measured: Baseline (before surgery); 1 day and 1 week after surgery

  4. Intraocular pressure in both groups

    Unit of Intraocular pressure is mmHg.

    Measured: Baseline (before surgery); 1 day and 1 week after surgery

  5. visual acuity in both groups

    Visual acuity testing use Snellen-based letter charts,such as a Snellen score of 6/12 (20/40), indicating an observer can resolve details as small 2 minutes of visual angle, corresponds to a LogMAR of 0.3 (since the base-10 logarithm of 2 is 0.3)

    Measured: Baseline (before surgery); 1 day and 1 week after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2019
  2. Study start10 Oct 2023 (estimated)
  3. Primary completion10 Jan 2024 (estimated)
  4. Study completion30 Jan 2024 (estimated)

Why it stopped: change study sites

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
264 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03958929
Sponsor's protocol ID
2019-074-K-73
Status last verified
Apr 2023
First submitted
20 May 2019
Last updated
12 Apr 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Educational Video in people with Glaucoma, run by Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 12 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The mean satisfaction outcome over two follow-up visits (time frame: 1 day, 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in